Phenomic AI Tackles Drug Discovery with AI-driven High-throughput Phenotypic Screens Using Antibody-based Assays
Phenomic AI conducts high-throughput phenotypic screens using artificial intelligence to analyze the resulting microscopy images. I sat down with three Phenomic AI biologists, Allison Nixon, Max London, and Elizabeth Koch, to learn more about the company and it’s technology.
Dr. David Rimm on Antibodies, Reproducibility, and His Experience with BenchSci
Dr. David Rimm, Professor at Yale University, shares his perspectives on the challenges of finding antibodies, and how BenchSci has helped.
BenchSci Case Study: Vera C. Lattier on Antibodies for Discovering the Molecular Mechanisms of Congenital Myopathies
Vera C. Lattier, a PhD candidate at Oregon State University, tells us how she uses BenchSci to find antibodies for studying the molecular mechanisms of congenital myopathies.
Researcher Highlight: Ladan Gheiratmand, PhD
Meet a fellow scientist, Ladan Gheiratmand, and learn about centriolar satellite research!